LoginGet started
Picture of Merck KGaA logo

MRK — Merck KGaA Cashflow Statement

0.000.00%
de flag iconLast trade - 00:00
HealthcareBalancedLarge CapFalling Star
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual cashflow statement for Merck KGaA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,3241,9943,0653,3392,834
Depreciation
Non-Cash Items149-5962-27-34
Unusual Items
Other Non-Cash Items
Changes in Working Capital-561-396-273-1,083-896
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities2,8563,4774,6164,2593,784
Capital Expenditures-1,021-1,563-1,421-1,806-2,023
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-5,132223-157-937131
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-6,153-1,340-1,578-2,743-1,892
Financing Cash Flow Items-527-519-576-728-880
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities1,902-1,522-2,504-1,555-1,732
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1,390575543-46129